Lung Cancer Clinicians` Preferences for Adjuvant Chemotherapy (act) in Non-small-cell Lung Cancer (nsclc): What Makes It Worthwhile?

Sue-Anne Mclachlan; Brett Hughes; Malcolm Hudson; Chris Brown; Anne-Sophie Veillard; Nick Muljadi; Catherine Crombie; Tim Christmas; Michael Millward; Gavin Wright; Peter Flynn; Morgan Windsor; Martin Stockler; Prunella Blinman

Lung Cancer Clinicians` Preferences for Adjuvant Chemotherapy (act) in Non-small-cell Lung Cancer (nsclc): What Makes It Worthwhile?

Sue-Anne Mclachlan, Brett Hughes, Malcolm Hudson, Chris Brown, Anne-Sophie Veillard, Nick Muljadi, Catherine Crombie, Tim Christmas, Michael Millward, Gavin Wright, Peter Flynn, Morgan Windsor, Martin Stockler, Prunella Blinman

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S625-S625
Number of pages	1
Journal	Journal of Thoracic Oncology
Volume	8
Publication status	Published - Nov 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Mclachlan, S.-A., Hughes, B., Hudson, M., Brown, C., Veillard, A.-S., Muljadi, N., Crombie, C., Christmas, T., Millward, M., Wright, G., Flynn, P., Windsor, M., Stockler, M., & Blinman, P. (2013). Lung Cancer Clinicians` Preferences for Adjuvant Chemotherapy (act) in Non-small-cell Lung Cancer (nsclc): What Makes It Worthwhile? Journal of Thoracic Oncology, 8, S625-S625.

@article{57f4183c61f14d7cac1b3a83886ce009,

title = "Lung Cancer Clinicians` Preferences for Adjuvant Chemotherapy (act) in Non-small-cell Lung Cancer (nsclc): What Makes It Worthwhile?",

keywords = "Adjuvant chemotherapy, Clinician preferences, Non-small cell lung cancer",

author = "Sue-Anne Mclachlan and Brett Hughes and Malcolm Hudson and Chris Brown and Anne-Sophie Veillard and Nick Muljadi and Catherine Crombie and Tim Christmas and Michael Millward and Gavin Wright and Peter Flynn and Morgan Windsor and Martin Stockler and Prunella Blinman",

year = "2013",

month = nov,

language = "English",

volume = "8",

pages = "S625--S625",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Academic Press",

}

TY - JOUR

T1 - Lung Cancer Clinicians` Preferences for Adjuvant Chemotherapy (act) in Non-small-cell Lung Cancer (nsclc)

T2 - What Makes It Worthwhile?

AU - Mclachlan, Sue-Anne

AU - Hughes, Brett

AU - Hudson, Malcolm

AU - Brown, Chris

AU - Veillard, Anne-Sophie

AU - Muljadi, Nick

AU - Crombie, Catherine

AU - Christmas, Tim

AU - Millward, Michael

AU - Wright, Gavin

AU - Flynn, Peter

AU - Windsor, Morgan

AU - Stockler, Martin

AU - Blinman, Prunella

PY - 2013/11

Y1 - 2013/11

KW - Adjuvant chemotherapy

KW - Clinician preferences

KW - Non-small cell lung cancer

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=uwapure5-25&SrcAuth=WosAPI&KeyUT=WOS:000339624903040&DestLinkType=FullRecord&DestApp=WOS

M3 - Abstract/Meeting Abstract

SN - 1556-0864

VL - 8

SP - S625-S625

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

ER -

Lung Cancer Clinicians` Preferences for Adjuvant Chemotherapy (act) in Non-small-cell Lung Cancer (nsclc): What Makes It Worthwhile?

UN SDGs

Other files and links

Cite this